Efficient generation of human induced pluripotent stem cell (hiPSC)-derived human intestinal organoids (HIOs) would facilitate the development of in vitro models for a variety of diseases that affect the gastrointestinal tract, such as inflammatory bowel disease or Cystic Fibrosis. Here, we report a directed differentiation protocol for the generation of mesenchyme-free HIOs that can be primed towards more colonic or proximal intestinal lineages in serum-free defined conditions. Using aCDX2eGFPiPSC knock-in reporter line to track the emergence of hindgut progenitors, we follow the kinetics ofCDX2expression throughout directed differentiation, enabling the purification of intestinal progenitors and robust generation of mesenchyme-free organoids expressing characteristic markers of small intestinal or colonic epithelium. We employ HIOs generated in this way to measureCFTRfunction using cystic fibrosis patient-derived iPSC lines before and after correction of theCFTRmutation, demonstrating their future potential for disease modeling and therapeutic screening applications.
No takes yet. Share an insight, caveat, or question.
Mithal et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: